P. Helderman-van den Enden

Mortality Risk Associated With Truncating Founder Mutations in Titin.

A. Wilde, M. P. van den Berg, E. Sijbrands, 2019, Circulation. Genomic and precision medicine.

Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials.

K. Bushby, F. Muntoni, K. Anthony, 2011, Brain : a journal of neurology.

Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease.

P. de Knijff, M. Losekoot, M. Breuning, 2001, American journal of medical genetics.